View Future GrowthFufeng Group 過去の業績過去 基準チェック /36Fufeng Groupは、平均年間15.2%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 減少しています。収益は、平均年間2.8% 8.8%収益成長率で 成長しています。 Fufeng Groupの自己資本利益率は12.7%であり、純利益率は8.8%です。主要情報15.17%収益成長率15.35%EPS成長率Chemicals 業界の成長10.22%収益成長率8.76%株主資本利益率12.67%ネット・マージン8.84%前回の決算情報31 Dec 2025最近の業績更新お知らせ • Mar 16Fufeng Group Limited to Report Fiscal Year 2025 Results on Mar 26, 2026Fufeng Group Limited announced that they will report fiscal year 2025 results on Mar 26, 2026お知らせ • Aug 18Fufeng Group Limited to Report First Half, 2025 Results on Aug 28, 2025Fufeng Group Limited announced that they will report first half, 2025 results on Aug 28, 2025お知らせ • Mar 18Fufeng Group Limited to Report Fiscal Year 2024 Results on Mar 28, 2025Fufeng Group Limited announced that they will report fiscal year 2024 results on Mar 28, 2025Reported Earnings • Aug 31First half 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.61 in 1H 2023)First half 2024 results: EPS: CN¥0.41 (down from CN¥0.61 in 1H 2023). Revenue: CN¥13.4b (down 1.6% from 1H 2023). Net income: CN¥1.04b (down 32% from 1H 2023). Profit margin: 7.8% (down from 11% in 1H 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 20Fufeng Group Limited to Report First Half, 2024 Results on Aug 29, 2024Fufeng Group Limited announced that they will report first half, 2024 results on Aug 29, 2024Reported Earnings • Mar 28Full year 2023 earnings released: EPS: CN¥1.24 (vs CN¥1.52 in FY 2022)Full year 2023 results: EPS: CN¥1.24 (down from CN¥1.52 in FY 2022). Revenue: CN¥28.0b (up 1.9% from FY 2022). Net income: CN¥3.14b (down 19% from FY 2022). Profit margin: 11% (down from 14% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.5% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.すべての更新を表示Recent updatesDeclared Dividend • May 20Final dividend of HK$0.12 announcedShareholders will receive a dividend of HK$0.12. Ex-date: 2nd June 2026 Payment date: 30th June 2026 Dividend yield will be 8.1%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (32% earnings payout ratio) but not covered by cash flows (377% cash payout ratio). The dividend has increased by an average of 22% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 31% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Fiona Li was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.お知らせ • Mar 26Fufeng Group Limited, Annual General Meeting, May 29, 2026Fufeng Group Limited, Annual General Meeting, May 29, 2026.お知らせ • Mar 16Fufeng Group Limited to Report Fiscal Year 2025 Results on Mar 26, 2026Fufeng Group Limited announced that they will report fiscal year 2025 results on Mar 26, 2026お知らせ • Aug 18Fufeng Group Limited to Report First Half, 2025 Results on Aug 28, 2025Fufeng Group Limited announced that they will report first half, 2025 results on Aug 28, 2025お知らせ • May 29+ 1 more updateFufeng Group Limited Approves Special Final Dividend for the Year Ended 31 December 2024, Payable on or about 27 June 2025Fufeng Group Limited at its AGM held on May 29, 2025, approved special final dividend of 3 Hong Kong cents per share for the year ended 31 December 2024. The register of members of the Company will be closed from 4 June 2025 to 6 June 2025 (both dates inclusive), during which no transfer of shares will be registered. In order to qualify for the final dividend, all transfers of shares accompanied by the relevant share certificates must be lodged with the Company's branch registrar in Hong Kong, Tricor Investor Services Limited at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong not later than 4:30 p.m. on 3 June 2025. Such dividend will be distributed on or about 27 June 2025 to Shareholders whose names appear on the register of members of the Company on 6 June 2025.お知らせ • Mar 28Fufeng Group Limited, Annual General Meeting, May 29, 2025Fufeng Group Limited, Annual General Meeting, May 29, 2025.お知らせ • Mar 18Fufeng Group Limited to Report Fiscal Year 2024 Results on Mar 28, 2025Fufeng Group Limited announced that they will report fiscal year 2024 results on Mar 28, 2025Declared Dividend • Sep 01First half dividend of HK$0.18 announcedShareholders will receive a dividend of HK$0.18. Ex-date: 10th September 2024 Payment date: 30th September 2024 Dividend yield will be 12%, which is higher than the industry average of 8.1%. Sustainability & Growth Dividend is covered by earnings (33% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 44% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Aug 31First half 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.61 in 1H 2023)First half 2024 results: EPS: CN¥0.41 (down from CN¥0.61 in 1H 2023). Revenue: CN¥13.4b (down 1.6% from 1H 2023). Net income: CN¥1.04b (down 32% from 1H 2023). Profit margin: 7.8% (down from 11% in 1H 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 29+ 2 more updatesFufeng Group Limited Announces Special Interim Dividend for the Six Months Ended 30 June 2024, Payable on 30 September 2024Fufeng Group Limited announced special interim dividend of HKD 0.02 per share for the six months ended 30 June 2024. Ex-dividend date is 10 September 2024. Record date is 13 September 2024. Payment date is 30 September 2024.お知らせ • Aug 20Fufeng Group Limited to Report First Half, 2024 Results on Aug 29, 2024Fufeng Group Limited announced that they will report first half, 2024 results on Aug 29, 2024Valuation Update With 7 Day Price Move • Jul 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to HK$4.43, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 9x in the Chemicals industry in Hong Kong. Total returns to shareholders of 148% over the past three years.Upcoming Dividend • May 27Upcoming dividend of HK$0.35 per shareEligible shareholders must have bought the stock before 03 June 2024. Payment date: 28 June 2024. Payout ratio is a comfortable 33% but the company is not cash flow positive. Trailing yield: 7.2%. Lower than top quartile of Hong Kong dividend payers (7.6%). Higher than average of industry peers (4.7%).お知らせ • Mar 28Fufeng Group Limited, Annual General Meeting, May 30, 2024Fufeng Group Limited, Annual General Meeting, May 30, 2024.Reported Earnings • Mar 28Full year 2023 earnings released: EPS: CN¥1.24 (vs CN¥1.52 in FY 2022)Full year 2023 results: EPS: CN¥1.24 (down from CN¥1.52 in FY 2022). Revenue: CN¥28.0b (up 1.9% from FY 2022). Net income: CN¥3.14b (down 19% from FY 2022). Profit margin: 11% (down from 14% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.5% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.お知らせ • Mar 27Fufeng Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024Fufeng Group Limited proposed final dividend of HKD 0.22 per share for the year ended 31 December 2023. Date of shareholders' approval is 30 May 2024. Ex-dividend date is 03 June 2024. Record date is 07 June 2024. Payment date is 28 June 2024.お知らせ • Mar 16Fufeng Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024Fufeng Group Limited announced that they will report fiscal year 2023 results on Mar 27, 2024Upcoming Dividend • Sep 11Upcoming dividend of HK$0.23 per share at 13% yieldEligible shareholders must have bought the stock before 18 September 2023. Payment date: 13 October 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (7.6%).Reported Earnings • Sep 01First half 2023 earnings released: EPS: CN¥0.61 (vs CN¥0.80 in 1H 2022)First half 2023 results: EPS: CN¥0.61 (down from CN¥0.80 in 1H 2022). Revenue: CN¥13.6b (up 5.0% from 1H 2022). Net income: CN¥1.54b (down 24% from 1H 2022). Profit margin: 11% (down from 16% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 31Fufeng Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 13 October 2023Fufeng Group Limited announced Interim Dividend of HKD 0.23 per share for the six months ended 30 June 2023. Record date is 22 September 2023. Payment date is 13 October 2023. Ex-dividend date is 18 September 2023.お知らせ • Aug 19Fufeng Group Limited to Report First Half, 2023 Results on Aug 30, 2023Fufeng Group Limited announced that they will report first half, 2023 results on Aug 30, 2023お知らせ • Aug 01Fufeng Group Limited Announces Management Changes, Effect from 1 August 2023The board of directors of Fufeng Group Limited announced that Mr. Lee Wai Yin (Mr. Lee) has tendered his resignation as company secretary and authorised representative of the Company with effect from 1 August 2023. The Board announced that Mr. Yau Wing Yiu (Mr. Yau) will be appointed as the company secretary and authorised representative of the Company with effect from 1 August 2023. Mr. Yau joined the Group as chief financial officer since June 2021. Mr. Yau is an associate member of the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. The biography of Mr. Yau could be referenced to the 2022 annual report of the Company.Upcoming Dividend • May 29Upcoming dividend of HK$0.33 per share at 13% yieldEligible shareholders must have bought the stock before 05 June 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (7.3%).お知らせ • May 26+ 1 more updateFufeng Group Limited Approves Special Final Dividend for the Year Ended 31 December 2022Fufeng Group Limited's AGM, held on May 25, 2023, approved special final dividend of HK 4.1 cents per share for the year ended 31 December 2022.Reported Earnings • Mar 31Full year 2022 earnings released: EPS: CN¥1.52 (vs CN¥0.51 in FY 2021)Full year 2022 results: EPS: CN¥1.52 (up from CN¥0.51 in FY 2021). Revenue: CN¥27.5b (up 28% from FY 2021). Net income: CN¥3.86b (up 202% from FY 2021). Profit margin: 14% (up from 5.9% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 31First half 2022 earnings released: EPS: CN¥0.80 (vs CN¥0.23 in 1H 2021)First half 2022 results: EPS: CN¥0.80 (up from CN¥0.23 in 1H 2021). Revenue: CN¥12.9b (up 36% from 1H 2021). Net income: CN¥2.03b (up 243% from 1H 2021). Profit margin: 16% (up from 6.2% in 1H 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 9.7% while the Chemicals industry in Hong Kong is not expected to grow. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 5% per year.Valuation Update With 7 Day Price Move • Jul 03Investor sentiment improved over the past weekAfter last week's 21% share price gain to HK$5.03, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 39% over the past three years.Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$4.33, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 27% over the past three years.Upcoming Dividend • May 30Upcoming dividend of HK$0.12 per shareEligible shareholders must have bought the stock before 06 June 2022. Payment date: 30 June 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 5.1%. Lower than top quartile of Hong Kong dividend payers (7.8%). In line with average of industry peers (5.4%).Reported Earnings • Apr 27Full year 2021 earnings released: EPS: CN¥0.51 (vs CN¥0.25 in FY 2020)Full year 2021 results: EPS: CN¥0.51 (up from CN¥0.25 in FY 2020). Revenue: CN¥21.5b (up 29% from FY 2020). Net income: CN¥1.28b (up 103% from FY 2020). Profit margin: 5.9% (up from 3.8% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 19%, compared to a 12% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Recent Insider Transactions • Apr 06Principal Founder & Executive Chairman recently bought HK$3.2m worth of stockOn the 1st of April, Xuechun Li bought around 1m shares on-market at roughly HK$3.18 per share. This was the largest purchase by an insider in the last 3 months. This was Xuechun's only on-market trade for the last 12 months.Reported Earnings • Apr 01Full year 2021 earnings released: EPS: CN¥0.51 (vs CN¥0.25 in FY 2020)Full year 2021 results: EPS: CN¥0.51 (up from CN¥0.25 in FY 2020). Revenue: CN¥21.5b (up 29% from FY 2020). Net income: CN¥1.28b (up 103% from FY 2020). Profit margin: 5.9% (up from 3.8% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 3.2% compared to a 8.3% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improved over the past weekAfter last week's 17% share price gain to HK$2.87, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total loss to shareholders of 20% over the past three years.Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$3.12, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 14% over the past three years.Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 19% share price gain to HK$3.12, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 17% over the past three years.Upcoming Dividend • Sep 06Upcoming dividend of HK$0.098 per shareEligible shareholders must have bought the stock before 13 September 2021. Payment date: 30 September 2021. Trailing yield: 4.8%. Lower than top quartile of Hong Kong dividend payers (6.6%). Higher than average of industry peers (2.9%).Reported Earnings • Sep 03First half 2021 earnings released: EPS CN¥0.23 (vs CN¥0.15 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CN¥9.52b (up 17% from 1H 2020). Net income: CN¥591.0m (up 56% from 1H 2020). Profit margin: 6.2% (up from 4.6% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Sep 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$2.92, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total loss to shareholders of 6.2% over the past three years.Executive Departure • Jun 16Chief Financial Officer Yuan Chen has left the companyOn the 15th of June, Yuan Chen's tenure as Chief Financial Officer ended after 3.9 years in the role. We don't have any record of a personal shareholding under Yuan's name. A total of 3 executives have left over the last 12 months. The current median tenure of the management team is 3.92 years.Upcoming Dividend • May 31Upcoming dividend of HK$0.041 per shareEligible shareholders must have bought the stock before 07 June 2021. Payment date: 30 June 2021. Trailing yield: 3.2%. Lower than top quartile of Hong Kong dividend payers (6.0%). Lower than average of industry peers (3.6%).Reported Earnings • Apr 25Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.45 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥16.7b (up 3.2% from FY 2019). Net income: CN¥629.9m (down 45% from FY 2019). Profit margin: 3.8% (down from 7.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 13% per year.Executive Departure • Apr 01Independent Non-Executive Director has left the companyOn the 1st of April, Zheng Yu's tenure as Independent Non-Executive Director ended after 8.3 years in the role. We don't have any record of a personal shareholding under Zheng's name. A total of 3 executives have left over the last 12 months.Reported Earnings • Mar 26Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.45 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥16.7b (up 3.2% from FY 2019). Net income: CN¥629.9m (down 45% from FY 2019). Profit margin: 3.8% (down from 7.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 14% per year.Is New 90 Day High Low • Feb 20New 90-day high: HK$3.76The company is up 33% from its price of HK$2.82 on 20 November 2020. The Hong Kong market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 32% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is HK$12.17 per share.Valuation Update With 7 Day Price Move • Feb 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥3.64, the stock is trading at a trailing P/E ratio of 8.5x, up from the previous P/E ratio of 7.3x. This compares to an average P/E of 9x in the Chemicals industry in Hong Kong. Total return to shareholders over the past three years is a loss of 14%.Is New 90 Day High Low • Jan 18New 90-day high: HK$3.10The company is up 25% from its price of HK$2.48 on 21 October 2020. The Hong Kong market is up 16% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 27% over the same period.Is New 90 Day High Low • Nov 16New 90-day high: HK$2.80The company is up 4.0% from its price of HK$2.69 on 18 August 2020. The Hong Kong market is also up 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is down 4.0% over the same period.Recent Insider Transactions • Oct 06CEO & Executive Director recently bought HK$1.3m worth of stockOn the 30th of September, Deheng Li bought around 541k shares on-market at roughly HK$2.40 per share. This was the largest purchase by an insider in the last 3 months. This was Deheng's only on-market trade for the last 12 months.Is New 90 Day High Low • Sep 22New 90-day low: HK$2.43The company is down 5.0% from its price of HK$2.56 on 24 June 2020. The Hong Kong market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is HK$10.93 per share.収支内訳Fufeng Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史SZSC:546 収益、費用、利益 ( )CNY Millions日付収益収益G+A経費研究開発費31 Dec 2527,8792,4653,348030 Sep 2528,1142,7643,265030 Jun 2528,3493,0633,181031 Mar 2528,0532,6883,115031 Dec 2427,7572,3123,048030 Sep 2427,7762,4802,994030 Jun 2427,7952,6472,941031 Mar 2427,9012,8962,975031 Dec 2328,0073,1443,008030 Sep 2328,0653,2592,968030 Jun 2328,1243,3732,927031 Mar 2327,7993,6172,863031 Dec 2227,4753,8612,799030 Sep 2226,2123,2882,738030 Jun 2224,9502,7162,677031 Mar 2223,2451,9982,522031 Dec 2121,5401,2812,367030 Sep 2119,7911,0612,277030 Jun 2118,0438422,188031 Mar 2117,3677362,200031 Dec 2016,6916302,213030 Sep 2016,6637672,215030 Jun 2016,6369042,218031 Mar 2016,4031,0212,185031 Dec 1916,1711,1372,152030 Sep 1915,5141,6402,030030 Jun 1914,8582,1431,907031 Mar 1914,3111,9941,804031 Dec 1813,7651,8451,700030 Sep 1813,5991,4501,630030 Jun 1813,4331,0551,559031 Mar 1813,2331,2191,524031 Dec 1713,0341,3821,488030 Sep 1712,7671,3841,451030 Jun 1712,5011,3851,414031 Mar 1712,1521,2391,370031 Dec 1611,8031,0931,326030 Sep 1611,4557731,298030 Jun 1611,1074531,269031 Mar 1611,1664851,246031 Dec 1511,2265161,222030 Sep 1511,2246411,198030 Jun 1511,2227651,1750質の高い収益: 546は 高品質の収益 を持っています。利益率の向上: 546の現在の純利益率 (8.8%)は、昨年(8.3%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 546の収益は過去 5 年間で年間15.2%増加しました。成長の加速: 546の過去 1 年間の収益成長率 ( 6.6% ) は、5 年間の平均 ( 年間15.2%を下回っています。収益対業界: 546の過去 1 年間の収益成長率 ( 6.6% ) Chemicals業界12.2%を上回りませんでした。株主資本利益率高いROE: 546の 自己資本利益率 ( 12.7% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 23:12終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Fufeng Group Limited 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。15 アナリスト機関Lei YangCGS Internationalnull nullChina International Capital Corporation LimitedYilin HouChina International Capital Corporation Limited12 その他のアナリストを表示
お知らせ • Mar 16Fufeng Group Limited to Report Fiscal Year 2025 Results on Mar 26, 2026Fufeng Group Limited announced that they will report fiscal year 2025 results on Mar 26, 2026
お知らせ • Aug 18Fufeng Group Limited to Report First Half, 2025 Results on Aug 28, 2025Fufeng Group Limited announced that they will report first half, 2025 results on Aug 28, 2025
お知らせ • Mar 18Fufeng Group Limited to Report Fiscal Year 2024 Results on Mar 28, 2025Fufeng Group Limited announced that they will report fiscal year 2024 results on Mar 28, 2025
Reported Earnings • Aug 31First half 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.61 in 1H 2023)First half 2024 results: EPS: CN¥0.41 (down from CN¥0.61 in 1H 2023). Revenue: CN¥13.4b (down 1.6% from 1H 2023). Net income: CN¥1.04b (down 32% from 1H 2023). Profit margin: 7.8% (down from 11% in 1H 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 20Fufeng Group Limited to Report First Half, 2024 Results on Aug 29, 2024Fufeng Group Limited announced that they will report first half, 2024 results on Aug 29, 2024
Reported Earnings • Mar 28Full year 2023 earnings released: EPS: CN¥1.24 (vs CN¥1.52 in FY 2022)Full year 2023 results: EPS: CN¥1.24 (down from CN¥1.52 in FY 2022). Revenue: CN¥28.0b (up 1.9% from FY 2022). Net income: CN¥3.14b (down 19% from FY 2022). Profit margin: 11% (down from 14% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.5% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Declared Dividend • May 20Final dividend of HK$0.12 announcedShareholders will receive a dividend of HK$0.12. Ex-date: 2nd June 2026 Payment date: 30th June 2026 Dividend yield will be 8.1%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (32% earnings payout ratio) but not covered by cash flows (377% cash payout ratio). The dividend has increased by an average of 22% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 31% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Fiona Li was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
お知らせ • Mar 26Fufeng Group Limited, Annual General Meeting, May 29, 2026Fufeng Group Limited, Annual General Meeting, May 29, 2026.
お知らせ • Mar 16Fufeng Group Limited to Report Fiscal Year 2025 Results on Mar 26, 2026Fufeng Group Limited announced that they will report fiscal year 2025 results on Mar 26, 2026
お知らせ • Aug 18Fufeng Group Limited to Report First Half, 2025 Results on Aug 28, 2025Fufeng Group Limited announced that they will report first half, 2025 results on Aug 28, 2025
お知らせ • May 29+ 1 more updateFufeng Group Limited Approves Special Final Dividend for the Year Ended 31 December 2024, Payable on or about 27 June 2025Fufeng Group Limited at its AGM held on May 29, 2025, approved special final dividend of 3 Hong Kong cents per share for the year ended 31 December 2024. The register of members of the Company will be closed from 4 June 2025 to 6 June 2025 (both dates inclusive), during which no transfer of shares will be registered. In order to qualify for the final dividend, all transfers of shares accompanied by the relevant share certificates must be lodged with the Company's branch registrar in Hong Kong, Tricor Investor Services Limited at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong not later than 4:30 p.m. on 3 June 2025. Such dividend will be distributed on or about 27 June 2025 to Shareholders whose names appear on the register of members of the Company on 6 June 2025.
お知らせ • Mar 28Fufeng Group Limited, Annual General Meeting, May 29, 2025Fufeng Group Limited, Annual General Meeting, May 29, 2025.
お知らせ • Mar 18Fufeng Group Limited to Report Fiscal Year 2024 Results on Mar 28, 2025Fufeng Group Limited announced that they will report fiscal year 2024 results on Mar 28, 2025
Declared Dividend • Sep 01First half dividend of HK$0.18 announcedShareholders will receive a dividend of HK$0.18. Ex-date: 10th September 2024 Payment date: 30th September 2024 Dividend yield will be 12%, which is higher than the industry average of 8.1%. Sustainability & Growth Dividend is covered by earnings (33% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 44% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Aug 31First half 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.61 in 1H 2023)First half 2024 results: EPS: CN¥0.41 (down from CN¥0.61 in 1H 2023). Revenue: CN¥13.4b (down 1.6% from 1H 2023). Net income: CN¥1.04b (down 32% from 1H 2023). Profit margin: 7.8% (down from 11% in 1H 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 29+ 2 more updatesFufeng Group Limited Announces Special Interim Dividend for the Six Months Ended 30 June 2024, Payable on 30 September 2024Fufeng Group Limited announced special interim dividend of HKD 0.02 per share for the six months ended 30 June 2024. Ex-dividend date is 10 September 2024. Record date is 13 September 2024. Payment date is 30 September 2024.
お知らせ • Aug 20Fufeng Group Limited to Report First Half, 2024 Results on Aug 29, 2024Fufeng Group Limited announced that they will report first half, 2024 results on Aug 29, 2024
Valuation Update With 7 Day Price Move • Jul 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to HK$4.43, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 9x in the Chemicals industry in Hong Kong. Total returns to shareholders of 148% over the past three years.
Upcoming Dividend • May 27Upcoming dividend of HK$0.35 per shareEligible shareholders must have bought the stock before 03 June 2024. Payment date: 28 June 2024. Payout ratio is a comfortable 33% but the company is not cash flow positive. Trailing yield: 7.2%. Lower than top quartile of Hong Kong dividend payers (7.6%). Higher than average of industry peers (4.7%).
お知らせ • Mar 28Fufeng Group Limited, Annual General Meeting, May 30, 2024Fufeng Group Limited, Annual General Meeting, May 30, 2024.
Reported Earnings • Mar 28Full year 2023 earnings released: EPS: CN¥1.24 (vs CN¥1.52 in FY 2022)Full year 2023 results: EPS: CN¥1.24 (down from CN¥1.52 in FY 2022). Revenue: CN¥28.0b (up 1.9% from FY 2022). Net income: CN¥3.14b (down 19% from FY 2022). Profit margin: 11% (down from 14% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.5% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 27Fufeng Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024Fufeng Group Limited proposed final dividend of HKD 0.22 per share for the year ended 31 December 2023. Date of shareholders' approval is 30 May 2024. Ex-dividend date is 03 June 2024. Record date is 07 June 2024. Payment date is 28 June 2024.
お知らせ • Mar 16Fufeng Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024Fufeng Group Limited announced that they will report fiscal year 2023 results on Mar 27, 2024
Upcoming Dividend • Sep 11Upcoming dividend of HK$0.23 per share at 13% yieldEligible shareholders must have bought the stock before 18 September 2023. Payment date: 13 October 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (7.6%).
Reported Earnings • Sep 01First half 2023 earnings released: EPS: CN¥0.61 (vs CN¥0.80 in 1H 2022)First half 2023 results: EPS: CN¥0.61 (down from CN¥0.80 in 1H 2022). Revenue: CN¥13.6b (up 5.0% from 1H 2022). Net income: CN¥1.54b (down 24% from 1H 2022). Profit margin: 11% (down from 16% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 31Fufeng Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 13 October 2023Fufeng Group Limited announced Interim Dividend of HKD 0.23 per share for the six months ended 30 June 2023. Record date is 22 September 2023. Payment date is 13 October 2023. Ex-dividend date is 18 September 2023.
お知らせ • Aug 19Fufeng Group Limited to Report First Half, 2023 Results on Aug 30, 2023Fufeng Group Limited announced that they will report first half, 2023 results on Aug 30, 2023
お知らせ • Aug 01Fufeng Group Limited Announces Management Changes, Effect from 1 August 2023The board of directors of Fufeng Group Limited announced that Mr. Lee Wai Yin (Mr. Lee) has tendered his resignation as company secretary and authorised representative of the Company with effect from 1 August 2023. The Board announced that Mr. Yau Wing Yiu (Mr. Yau) will be appointed as the company secretary and authorised representative of the Company with effect from 1 August 2023. Mr. Yau joined the Group as chief financial officer since June 2021. Mr. Yau is an associate member of the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. The biography of Mr. Yau could be referenced to the 2022 annual report of the Company.
Upcoming Dividend • May 29Upcoming dividend of HK$0.33 per share at 13% yieldEligible shareholders must have bought the stock before 05 June 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (7.3%).
お知らせ • May 26+ 1 more updateFufeng Group Limited Approves Special Final Dividend for the Year Ended 31 December 2022Fufeng Group Limited's AGM, held on May 25, 2023, approved special final dividend of HK 4.1 cents per share for the year ended 31 December 2022.
Reported Earnings • Mar 31Full year 2022 earnings released: EPS: CN¥1.52 (vs CN¥0.51 in FY 2021)Full year 2022 results: EPS: CN¥1.52 (up from CN¥0.51 in FY 2021). Revenue: CN¥27.5b (up 28% from FY 2021). Net income: CN¥3.86b (up 202% from FY 2021). Profit margin: 14% (up from 5.9% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 31First half 2022 earnings released: EPS: CN¥0.80 (vs CN¥0.23 in 1H 2021)First half 2022 results: EPS: CN¥0.80 (up from CN¥0.23 in 1H 2021). Revenue: CN¥12.9b (up 36% from 1H 2021). Net income: CN¥2.03b (up 243% from 1H 2021). Profit margin: 16% (up from 6.2% in 1H 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 9.7% while the Chemicals industry in Hong Kong is not expected to grow. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 5% per year.
Valuation Update With 7 Day Price Move • Jul 03Investor sentiment improved over the past weekAfter last week's 21% share price gain to HK$5.03, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 39% over the past three years.
Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$4.33, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 27% over the past three years.
Upcoming Dividend • May 30Upcoming dividend of HK$0.12 per shareEligible shareholders must have bought the stock before 06 June 2022. Payment date: 30 June 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 5.1%. Lower than top quartile of Hong Kong dividend payers (7.8%). In line with average of industry peers (5.4%).
Reported Earnings • Apr 27Full year 2021 earnings released: EPS: CN¥0.51 (vs CN¥0.25 in FY 2020)Full year 2021 results: EPS: CN¥0.51 (up from CN¥0.25 in FY 2020). Revenue: CN¥21.5b (up 29% from FY 2020). Net income: CN¥1.28b (up 103% from FY 2020). Profit margin: 5.9% (up from 3.8% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 19%, compared to a 12% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Recent Insider Transactions • Apr 06Principal Founder & Executive Chairman recently bought HK$3.2m worth of stockOn the 1st of April, Xuechun Li bought around 1m shares on-market at roughly HK$3.18 per share. This was the largest purchase by an insider in the last 3 months. This was Xuechun's only on-market trade for the last 12 months.
Reported Earnings • Apr 01Full year 2021 earnings released: EPS: CN¥0.51 (vs CN¥0.25 in FY 2020)Full year 2021 results: EPS: CN¥0.51 (up from CN¥0.25 in FY 2020). Revenue: CN¥21.5b (up 29% from FY 2020). Net income: CN¥1.28b (up 103% from FY 2020). Profit margin: 5.9% (up from 3.8% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 3.2% compared to a 8.3% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improved over the past weekAfter last week's 17% share price gain to HK$2.87, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total loss to shareholders of 20% over the past three years.
Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$3.12, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 14% over the past three years.
Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 19% share price gain to HK$3.12, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 17% over the past three years.
Upcoming Dividend • Sep 06Upcoming dividend of HK$0.098 per shareEligible shareholders must have bought the stock before 13 September 2021. Payment date: 30 September 2021. Trailing yield: 4.8%. Lower than top quartile of Hong Kong dividend payers (6.6%). Higher than average of industry peers (2.9%).
Reported Earnings • Sep 03First half 2021 earnings released: EPS CN¥0.23 (vs CN¥0.15 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CN¥9.52b (up 17% from 1H 2020). Net income: CN¥591.0m (up 56% from 1H 2020). Profit margin: 6.2% (up from 4.6% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Sep 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$2.92, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total loss to shareholders of 6.2% over the past three years.
Executive Departure • Jun 16Chief Financial Officer Yuan Chen has left the companyOn the 15th of June, Yuan Chen's tenure as Chief Financial Officer ended after 3.9 years in the role. We don't have any record of a personal shareholding under Yuan's name. A total of 3 executives have left over the last 12 months. The current median tenure of the management team is 3.92 years.
Upcoming Dividend • May 31Upcoming dividend of HK$0.041 per shareEligible shareholders must have bought the stock before 07 June 2021. Payment date: 30 June 2021. Trailing yield: 3.2%. Lower than top quartile of Hong Kong dividend payers (6.0%). Lower than average of industry peers (3.6%).
Reported Earnings • Apr 25Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.45 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥16.7b (up 3.2% from FY 2019). Net income: CN¥629.9m (down 45% from FY 2019). Profit margin: 3.8% (down from 7.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 13% per year.
Executive Departure • Apr 01Independent Non-Executive Director has left the companyOn the 1st of April, Zheng Yu's tenure as Independent Non-Executive Director ended after 8.3 years in the role. We don't have any record of a personal shareholding under Zheng's name. A total of 3 executives have left over the last 12 months.
Reported Earnings • Mar 26Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.45 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥16.7b (up 3.2% from FY 2019). Net income: CN¥629.9m (down 45% from FY 2019). Profit margin: 3.8% (down from 7.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 14% per year.
Is New 90 Day High Low • Feb 20New 90-day high: HK$3.76The company is up 33% from its price of HK$2.82 on 20 November 2020. The Hong Kong market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 32% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is HK$12.17 per share.
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥3.64, the stock is trading at a trailing P/E ratio of 8.5x, up from the previous P/E ratio of 7.3x. This compares to an average P/E of 9x in the Chemicals industry in Hong Kong. Total return to shareholders over the past three years is a loss of 14%.
Is New 90 Day High Low • Jan 18New 90-day high: HK$3.10The company is up 25% from its price of HK$2.48 on 21 October 2020. The Hong Kong market is up 16% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 27% over the same period.
Is New 90 Day High Low • Nov 16New 90-day high: HK$2.80The company is up 4.0% from its price of HK$2.69 on 18 August 2020. The Hong Kong market is also up 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is down 4.0% over the same period.
Recent Insider Transactions • Oct 06CEO & Executive Director recently bought HK$1.3m worth of stockOn the 30th of September, Deheng Li bought around 541k shares on-market at roughly HK$2.40 per share. This was the largest purchase by an insider in the last 3 months. This was Deheng's only on-market trade for the last 12 months.
Is New 90 Day High Low • Sep 22New 90-day low: HK$2.43The company is down 5.0% from its price of HK$2.56 on 24 June 2020. The Hong Kong market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is HK$10.93 per share.